Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards providing pursuant to Section 13(a) of the Exchange Act. ☐
LightPath Technologies, Inc.
On November 10, 2026, LightPath Technologies, Inc. issued a press release announcing the results for its fiscal 2027 first quarter ended September 30, 2026. A copy of the Press Release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Report to be signed in its behalf by the undersigned, thereunto duly authorized.
Exhibit 99.1
LightPath Technologies Reports Fiscal 2027 First Quarter Financial Results
ORLANDO, FL – November 10, 2026 – LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal 2027 first quarter ended September 30, 2026.
Financial Summary:
| |
|
Three Months Ended September 30,
|
|
|
$ in millions
|
|
2026
|
|
|
2025
|
|
|
% Change
|
|
|
Revenue
|
|
$ |
20.8 |
|
|
$ |
15.1 |
|
|
|
37.9 |
% |
|
Gross Profit
|
|
$ |
8.6 |
|
|
$ |
4.5 |
|
|
|
91.9 |
% |
|
Operating Expenses*
|
|
$ |
10.8 |
|
|
$ |
7.0 |
|
|
|
54.1 |
% |
|
Net Loss
|
|
$ |
(1.7 |
) |
|
$ |
(2.9 |
) |
|
|
41.2 |
% |
|
Adjusted EBITDA** (non-GAAP)
|
|
$ |
1.3 |
|
|
$ |
0.4 |
|
|
|
252.1 |
% |
*Reconciliation of this non-GAAP financial measure is provided below. Percentage change for net loss is calculated on absolute values.
First Quarter Fiscal 2027 & Subsequent Highlights:
| |
●
|
Grew order backlog to a record of approximately $132.9 million as of September 30, 2026, up 20% from $110.9 million at June 30, 2026 and up 54% from $86.0 million at September 30, 2025, with approximately $110.8 million requested by customers for delivery within the next twelve months. |
| |
●
|
Secured more than $30 million of follow-on counter-unmanned aircraft system (“C-UAS”) orders from July through October 2026, including more than $19 million of optical assembly orders from a leading C-UAS and defense systems supplier — double that customer’s total for all of fiscal 2026 — and an $11 million infrared camera order from a leading global technology customer. |
| |
●
|
Received an order in October 2026 from a key defense customer for over 50,000 optical assemblies for drone camera systems as the U.S. and its allies rapidly scale up drone procurement. |
| |
●
|
Awarded a funded prototype agreement under the Department of War’s Critical Low-risk Electro-optic Alternatives for Resilience (“CLEAR”) program to further develop BlackDiamond™ chalcogenide glass and optics as germanium alternatives for defense electro-optic and infrared (“EO/IR”) systems. |
| |
●
|
Strengthened imaging systems leadership with the promotion of Michael Amorelli to VP Engineering, Imaging Systems, and the appointment of former Anduril Industries production leader Scott Payette as Vice President of LightPath and General Manager of G5 Infrared LLC (“G5 Infrared”). |
| |
●
|
Completed the previously announced sale of the Company’s China subsidiary, LightPath Optical Instrumentation (Zhenjiang) Co., Ltd. (“LPOIZ”), as of October 30, 2026, as a result of which LightPath no longer has facilities or operations based in China. |
Management Commentary
Sam Rubin, President and Chief Executive Officer of LightPath, said: “Fiscal 2027 is off to a strong start, led by backlog, a key indicator of our expected future revenue trends. New orders significantly outpaced shipments during the first quarter, lifting backlog by $22 million to a record $132.9 million, with approximately $110.8 million of it requested by customers for delivery over the next twelve months.
“The composition of our revenue continues to be more favorable as well. Revenue grew 38% year-over-year to $20.8 million, and assemblies and modules accounted for 51% of the total, up from 40% a year ago. That shift toward higher-value cameras and optical assemblies lifted gross margin to 41.4%, and we generated positive adjusted EBITDA for the fifth consecutive quarter while more than doubling our investment in new product development.
“Demand continues to build in optical assemblies and infrared cameras, two of our three projected growth pillars alongside large defense programs. A leading C-UAS supplier has placed more than $19 million of follow-on optical assembly orders with us since July 1, a leading global technology customer added an $11 million follow-on camera order, and we recently received an order for more than 50,000 optical assemblies for drone camera systems. At the same time, the Department of War selected BlackDiamond™ for a funded prototype agreement under its CLEAR program to develop and commercialize germanium alternatives for defense infrared systems – direct government support for the materials at the center of our platform.
“Our focus for the balance of fiscal 2027 is converting this backlog on schedule. We invested ahead of scheduled deliveries during the quarter, building inventory of critical materials and work-in-process and adding manufacturing capacity, including glass fabrication. With a strong balance sheet, a strengthened imaging systems leadership team under Scott Payette and Michael Amorelli, and the completion of our China divestiture in October 2026, we believe LightPath is well positioned to focus on scaling as a trusted, vertically integrated supplier of infrared optics and imaging systems,” concluded Rubin.
First Quarter Fiscal 2027 Financial Results
Revenue for the first quarter of fiscal 2027 increased 38% to $20.8 million, as compared to $15.1 million in the same quarter of the prior fiscal year. Revenue by product group for the first quarter of fiscal 2027 and the same quarter of the prior fiscal year was as follows:
|
Product Group Revenue ($ in millions)**
|
|
First Quarter of Fiscal 2027
|
|
|
First Quarter of Fiscal 2026
|
|
|
% Change
|
|
|
Infrared ("IR") Components
|
|
$ |
4.7 |
|
|
$ |
4.1 |
|
|
|
15%
|
|
|
Visible Components
|
|
$ |
4.6 |
|
|
$ |
3.8 |
|
|
|
19%
|
|
|
Assemblies & Modules
|
|
$ |
10.5 |
|
|
$ |
6.0 |
|
|
|
76%
|
|
|
Engineering Services
|
|
$ |
0.9 |
|
|
$ |
1.1 |
|
|
|
(18)%
|
|
** Numbers may not foot due to rounding. Certain fiscal 2026 amounts have been reclassified from infrared components to assemblies and modules to conform to the current classification.
Assemblies and modules revenue grew 76% to $10.5 million, or 51% of total revenue, as G5 Infrared’s camera and module sales increased on surveillance and C-UAS programs with global technology and defense customers. Infrared components revenue increased 15%, primarily driven by the addition of $1.1 million from Amorphous Materials (“AML”) following its acquisition in January 2026. This increase was partially offset by a decrease in sales to defense customers in Europe due to timing of orders.
Visible components revenue increased 19%, reflecting higher sales to industrial customers in Europe as well as U.S. defense customers and distributors. Engineering services revenue decreased $0.2 million, due to timing of certain customer programs.
Gross profit increased 92% to $8.6 million, or 41.4% of revenue, in the first quarter of fiscal 2027, as compared to $4.5 million, or 29.8% of revenue, in the prior year period. The more than 1,100 basis point expansion in gross margin primarily reflects revenue mix, as assemblies and modules, which typically earn higher margins, grew to 51% of total revenue from 40% a year earlier.
Operating expenses for the first quarter of fiscal 2027 were $10.8 million, as compared to $7.0 million in the prior year period. That increase primarily reflects $3.7 million of higher selling, general and administrative expenses (“SG&A”) – including $1.4 million of higher non-cash stock-based compensation, the addition of AML, which was not part of the prior year period, and IT investments required by defense customers’ cybersecurity standards – along with a $1.2 million increase in new product development costs as the Company added additional engineering staff. These increases were partially offset by the $1.1 million decrease in earnout fair value adjustments.
Net loss for the first quarter of fiscal 2027 improved to $1.7 million, or $0.02 per basic and diluted share, as compared to a net loss of $2.9 million, or $0.07 per basic and diluted share, in the prior year period. The improvement reflects higher gross profit, a lower earnout fair value adjustment and an increase in interest income.
Adjusted EBITDA* for the first quarter of fiscal 2027 increased to $1.3 million, or 6% of revenue, as compared to $0.4 million, or 2% of revenue, in the prior year period, reflecting five consecutive quarters of positive adjusted EBITDA.
Cash and cash equivalents as of September 30, 2026 totaled $82.9 million, as compared to $93.2 million as of June 30, 2026. The change primarily reflects a $10.1 million investment in working capital, largely advance purchases of critical materials to support customer demand and the Company’s growing backlog, and $2.5 million of capital expenditures, primarily to expand manufacturing capacity, including glass fabrication.
Total backlog as of September 30, 2026 was a record of approximately $132.9 million, an increase of 20% compared to $110.9 million as of June 30, 2026 and an increase of 54% compared to $86.0 million as of September 30, 2025. Approximately $110.8 million of the September 30, 2026 backlog is requested by customers for delivery within the next twelve months.
First Quarter Fiscal 2027 Earnings Call
Management will host an investor conference call at 5:00 p.m. Eastern time today, Tuesday, November 10, 2026, to discuss the Company's first quarter fiscal 2027 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:
Q1 FY2027 Earnings Conference Call
Date: Tuesday, November 10, 2026
Time: 5:00 p.m. Eastern time
U.S. Dial-in: 1-800-267-6316
International Dial-in: 1-203-518-9783
Conference ID: LIGHT
Webcast: LPTH Q1 FY2027 Earnings Conference Call
Please join at least five minutes before the start of the call to ensure timely participation.
A playback of the call will be available through Tuesday, November 24, 2026. To listen, please call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 11162913. A webcast replay will also be available using the webcast link above.
About LightPath Technologies
LightPath Technologies, Inc. (NASDAQ: LPTH) is a leading provider of next-generation optics and imaging systems for both defense and commercial applications. As a vertically integrated solutions provider with in-house engineering design support, LightPath's family of custom solutions range from proprietary BlackDiamond™ chalcogenide-based glass materials – sold under exclusive license from the U.S. Naval Research Laboratory – to complete infrared optical systems and thermal imaging assemblies. The Company's primary manufacturing footprint is located in Orlando, Florida with additional facilities in Texas, New Hampshire and Latvia. To learn more, please visit www.lightpath.com.
**Use of Non-GAAP Financial Measures
To provide investors with additional information regarding financial results, this press release includes references to EBITDA and adjusted EBITDA, which are non-GAAP financial measures. The Company calculates EBITDA by adjusting net income to exclude net interest expense, income tax expense or benefit, depreciation, and amortization. We also calculate adjusted EBITDA, which excludes, as applicable: (1) stock compensation expenses; (2) the loss on extinguishment of debt; (3) the effect of non-cash income or expenses associated with the fair value adjustments related to the acquisition earnout liabilities; (4) acquisition costs, including legal fees and due diligence; and (5) the effect of foreign exchange gains or losses.
A “non-GAAP financial measure” is generally defined as a numerical measure of a company’s historical or future performance that excludes or includes amounts, or is subject to adjustments, so as to be different from the most directly comparable measure calculated and presented in accordance with GAAP. The Company’s management believes that these non-GAAP financial measures, when considered together with the GAAP financial measures, provide information that is useful to investors in understanding period-over-period operating results separate and apart from items that may, or could, have a disproportionately positive or negative impact on results in any particular period. Management also believes that these non-GAAP financial measures enhance the ability of investors to analyze underlying business operations and understand performance. In addition, management may utilize these non-GAAP financial measures as guides in forecasting, budgeting, and planning. Non-GAAP financial measures should be considered in addition to, and not as a substitute for, or superior to, financial measures presented in accordance with GAAP. A reconciliation of these non-GAAP financial measures with the most directly comparable financial measures calculated in accordance with GAAP is presented in the table below.
LIGHTPATH TECHNOLOGIES, INC.
Reconciliation of Non-GAAP Financial Measures and Regulation G Disclosure
| |
|
(unaudited)
|
|
| |
|
Three Months Ended
|
|
| |
|
September 30,
|
|
| |
|
2026
|
|
|
2025
|
|
|
Net loss
|
|
$ |
(1,700,754 |
) |
|
$ |
(2,893,002 |
) |
|
Depreciation and amortization
|
|
|
1,479,568 |
|
|
|
1,218,948 |
|
|
Income tax provision
|
|
|
123,492 |
|
|
|
81,270 |
|
|
Interest (income) expense
|
|
|
(670,652 |
) |
|
|
268,853 |
|
|
EBITDA
|
|
$ |
(768,346 |
) |
|
$ |
(1,323,931 |
) |
|
Stock-based compensation
|
|
|
1,801,199 |
|
|
|
359,661 |
|
|
Change in fair value of acquisition earnout liabilities
|
|
|
196,633 |
|
|
|
1,282,529 |
|
|
Foreign exchange loss
|
|
|
40,848 |
|
|
|
42,543 |
|
|
Adjusted EBITDA
|
|
$ |
1,270,334 |
|
|
$ |
360,802 |
|
|
% of revenue
|
|
|
6 |
% |
|
|
2 |
% |
Forward-Looking Statements
This press release includes statements that constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “guidance,” “plan,” “estimate,” “will,” “would,” “project,” “maintain,” “intend,” “expect,” “anticipate,” “prospect,” “strategy,” “future,” “likely,” “may,” “should,” “believe,” “continue,” “opportunity,” “potential,” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, without limitation, statements regarding: (i) the Company’s ability to convert its backlog into revenue and the timing of such conversion; (ii) expectations regarding demand for germanium alternatives, including the Company’s BlackDiamond™ materials, and the effect of U.S. and allied procurement requirements and programs, including the CLEAR program, on the Company’s markets; (iii) expectations regarding demand for the Company’s products in C-UAS, drone and other defense applications; (iv) the Company’s plans to expand glass melting, fabrication, optical and assembly capacity and the anticipated level of capital expenditures in fiscal 2027; (v) expectations regarding the Company’s ability to scale as a vertically-integrated supplier of infrared products and imaging systems; and (vi) expectations regarding future revenue growth, gross margins and adjusted EBITDA. These forward-looking statements are based on information available at the time the statements are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the impact of varying demand for the Company’s products; the U.S. government’s initiatives to move away from using optical systems from certain foreign nations and the timing of related procurement decisions; the Company’s ability to expand manufacturing capacity and hire qualified personnel in a timely manner to meet demand; the inability of the Company to sustain profitable sales growth, convert inventory to cash, or reduce its costs to maintain competitive prices for its products; circumstances or developments that may make the Company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current and planned business initiatives; the Company’s reliance on a few key customers; the risk that the purchaser of LPOIZ does not perform its payment or supply obligations; the ability of the Company to obtain needed raw materials and components from its suppliers; the impact that international tariffs may have on our business and results of operations; the impact of political and other risks as a result of our sales to international customers and/or our sourcing of materials from international suppliers; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; geopolitical tensions and conflicts; the effects of steps that the Company could take to reduce operating costs; and those factors detailed by the Company in its public filings with the Securities and Exchange Commission (the “SEC”), including its Annual Report on Form 10-K and other filings with the SEC. Should one or more of these risks, uncertainties, or facts materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by the forward-looking statements contained herein. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Except as required under the federal securities laws and the rules and regulations of the SEC, we do not have any intention or obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.
Investor Relations Contact
Lucas A. Zimmerman
Managing Director
MZ Group – MZ North America
LPTH@mzgroup.us
+1 (949) 259-4987
LIGHTPATH TECHNOLOGIES, INC.
Condensed Consolidated Balance Sheets
(unaudited)
| |
|
September 30,
|
|
|
June 30,
|
|
| |
|
2026
|
|
|
2026
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
82,934,165 |
|
|
$ |
93,204,655 |
|
|
Trade accounts receivable, net of allowance of $112,025 and $63,162
|
|
|
15,182,690 |
|
|
|
15,112,908 |
|
|
Inventories, net
|
|
|
31,486,533 |
|
|
|
18,005,559 |
|
|
Prepaid expenses and deposits
|
|
|
2,420,098 |
|
|
|
3,457,300 |
|
|
Other current assets
|
|
|
132,534 |
|
|
|
116,028 |
|
|
Total current assets
|
|
|
132,156,020 |
|
|
|
129,896,450 |
|
| |
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
20,833,058 |
|
|
|
19,363,026 |
|
|
Operating lease right-of-use assets
|
|
|
7,828,475 |
|
|
|
8,115,887 |
|
|
Intangible assets, net
|
|
|
16,679,575 |
|
|
|
17,134,601 |
|
|
Goodwill
|
|
|
19,315,177 |
|
|
|
19,315,177 |
|
|
Deferred tax assets, net
|
|
|
85,902 |
|
|
|
85,902 |
|
|
Other assets
|
|
|
93,136 |
|
|
|
96,578 |
|
|
Total assets
|
|
$ |
196,991,343 |
|
|
$ |
194,007,621 |
|
|
Liabilities and Stockholders’ Equity
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
10,954,633 |
|
|
$ |
7,686,144 |
|
|
Accrued liabilities
|
|
|
11,889,102 |
|
|
|
12,779,784 |
|
|
Accrued payroll and benefits
|
|
|
2,793,391 |
|
|
|
4,139,586 |
|
|
Operating lease liabilities, current
|
|
|
1,202,483 |
|
|
|
1,189,908 |
|
|
Loans payable, current portion
|
|
|
111,815 |
|
|
|
112,317 |
|
|
Finance lease obligation, current portion
|
|
|
365,923 |
|
|
|
269,414 |
|
|
Total current liabilities
|
|
|
27,317,347 |
|
|
|
26,177,153 |
|
|
Deferred tax liabilities, net
|
|
|
95,994 |
|
|
|
95,084 |
|
|
Finance lease obligation, less current portion
|
|
|
803,150 |
|
|
|
392,796 |
|
|
Operating lease liabilities, noncurrent
|
|
|
8,569,553 |
|
|
|
8,888,227 |
|
|
Loans payable, less current portion
|
|
|
46,589 |
|
|
|
74,878 |
|
|
Total liabilities
|
|
|
36,832,633 |
|
|
|
35,628,138 |
|
| |
|
|
|
|
|
|
|
|
|
Commitments and Contingencies
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Series G Convertible Preferred Stock; $0.01 par value; 44,000 shares authorized; 6,492 and 6,492 shares issued and outstanding
|
|
$ |
8,906,686 |
|
|
$ |
8,906,686 |
|
| |
|
|
|
|
|
|
|
|
|
Stockholders’ equity:
|
|
|
|
|
|
|
|
|
|
Preferred stock: Series D, $0.01 par value, voting; 500,000 shares authorized; none issued and outstanding
|
|
|
— |
|
|
|
— |
|
|
Common stock: Class A, $0.01 par value, voting; 94,500,000 shares authorized; 70,087,678 and 69,963,045 shares issued and outstanding
|
|
|
700,877 |
|
|
|
699,630 |
|
|
Additional paid-in capital
|
|
|
402,146,557 |
|
|
|
398,726,619 |
|
|
Accumulated other comprehensive income
|
|
|
1,367,664 |
|
|
|
1,308,868 |
|
|
Accumulated deficit
|
|
|
(252,963,074 |
) |
|
|
(251,262,320 |
) |
|
Total stockholders’ equity
|
|
|
151,252,024 |
|
|
|
149,472,797 |
|
|
Total liabilities, convertible preferred stock and stockholders’ equity
|
|
$ |
196,991,343 |
|
|
$ |
194,007,621 |
|
LIGHTPATH TECHNOLOGIES, INC.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(unaudited)
| |
|
Three Months Ended
|
|
| |
|
September 30,
|
|
| |
|
2026
|
|
|
2025
|
|
|
Revenue, net
|
|
$ |
20,762,654 |
|
|
$ |
15,058,281 |
|
|
Cost of sales
|
|
|
12,160,790 |
|
|
|
10,575,709 |
|
|
Gross profit
|
|
|
8,601,864 |
|
|
|
4,482,572 |
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
8,048,205 |
|
|
|
4,383,870 |
|
|
New product development
|
|
|
2,036,377 |
|
|
|
867,428 |
|
|
Amortization of intangible assets
|
|
|
455,026 |
|
|
|
450,524 |
|
|
Change in fair value of acquisition earnout liabilities
|
|
|
196,633 |
|
|
|
1,282,529 |
|
|
Loss on disposal of property and equipment
|
|
|
30,849 |
|
|
|
3,999 |
|
|
Total operating expenses
|
|
|
10,767,090 |
|
|
|
6,988,350 |
|
|
Operating loss
|
|
|
(2,165,226 |
) |
|
|
(2,505,778 |
) |
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
Interest income (expense), net
|
|
|
670,652 |
|
|
|
(268,853 |
) |
|
Other expense, net
|
|
|
(82,688 |
) |
|
|
(37,101 |
) |
|
Total other income (expense)
|
|
|
587,964 |
|
|
|
(305,954 |
) |
|
Loss before income taxes
|
|
|
(1,577,262 |
) |
|
|
(2,811,732 |
) |
|
Income tax provision
|
|
|
123,492 |
|
|
|
81,270 |
|
|
Net loss
|
|
$ |
(1,700,754 |
) |
|
$ |
(2,893,002 |
) |
|
Foreign currency translation adjustment
|
|
|
58,796 |
|
|
|
92,383 |
|
|
Comprehensive loss
|
|
$ |
(1,641,958 |
) |
|
$ |
(2,800,619 |
) |
|
Loss per common share (basic)
|
|
$ |
(0.02 |
) |
|
$ |
(0.07 |
) |
|
Number of shares used in per share calculation (basic)
|
|
|
70,010,938 |
|
|
|
43,287,933 |
|
|
Loss per common share (diluted)
|
|
$ |
(0.02 |
) |
|
$ |
(0.07 |
) |
|
Number of shares used in per share calculation (diluted)
|
|
|
70,010,938 |
|
|
|
43,287,933 |
|
LIGHTPATH TECHNOLOGIES, INC.
Condensed Consolidated Statements of Changes in Stockholders' Equity
(unaudited)
| |
|
Temporary Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
| |
|
Series G Convertible
|
|
|
Class A
|
|
|
Additional
|
|
|
Other
|
|
|
|
|
|
|
Total
|
|
| |
|
Preferred Stock
|
|
|
Common Stock
|
|
|
Paid-in
|
|
|
Comprehensive
|
|
|
Accumulated
|
|
|
Stockholders’
|
|
| |
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Income
|
|
|
Deficit
|
|
|
Equity
|
|
|
Balances at June 30, 2026
|
|
|
6,492 |
|
|
$ |
8,906,686 |
|
|
|
69,963,045 |
|
|
$ |
699,630 |
|
|
$ |
398,726,619 |
|
|
$ |
1,308,868 |
|
|
$ |
(251,262,320 |
) |
|
$ |
149,472,797 |
|
|
Issuance of common stock for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Stock Purchase Plan
|
|
|
— |
|
|
|
— |
|
|
|
2,713 |
|
|
|
27 |
|
|
|
44,330 |
|
|
|
— |
|
|
|
— |
|
|
|
44,357 |
|
|
Exercise of stock options, RSUs & RSAs, net
|
|
|
— |
|
|
|
— |
|
|
|
661 |
|
|
|
7 |
|
|
|
(7 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Issuance of common stock for acquisition of Amorphous
|
|
|
— |
|
|
|
— |
|
|
|
121,259 |
|
|
|
1,213 |
|
|
|
1,621,666 |
|
|
|
— |
|
|
|
— |
|
|
|
1,622,879 |
|
|
Stock-based compensation on stock options, RSUs & RSAs
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,753,949 |
|
|
|
— |
|
|
|
— |
|
|
|
1,753,949 |
|
|
Foreign currency translation adjustment
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
58,796 |
|
|
|
— |
|
|
|
58,796 |
|
|
Net loss
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,700,754 |
) |
|
|
(1,700,754 |
) |
|
Balances at September 30, 2026
|
|
|
6,492 |
|
|
$ |
8,906,686 |
|
|
|
70,087,678 |
|
|
$ |
700,877 |
|
|
$ |
402,146,557 |
|
|
$ |
1,367,664 |
|
|
$ |
(252,963,074 |
) |
|
$ |
151,252,024 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at June 30, 2025
|
|
|
24,956 |
|
|
$ |
34,232,510 |
|
|
|
42,949,307 |
|
|
$ |
429,493 |
|
|
$ |
244,953,346 |
|
|
$ |
978,686 |
|
|
$ |
(230,716,757 |
) |
|
$ |
15,644,768 |
|
|
Issuance of common stock for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of stock options, RSUs & RSAs, net
|
|
|
— |
|
|
|
— |
|
|
|
8,583 |
|
|
|
86 |
|
|
|
(86 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Issuance of common stock under private equity placement
|
|
|
— |
|
|
|
— |
|
|
|
1,600,000 |
|
|
|
16,000 |
|
|
|
7,878,045 |
|
|
|
— |
|
|
|
— |
|
|
|
7,894,045 |
|
|
Issuance of common stock for acquisition of Visimid
|
|
|
— |
|
|
|
— |
|
|
|
112,323 |
|
|
|
1,123 |
|
|
|
348,877 |
|
|
|
— |
|
|
|
— |
|
|
|
350,000 |
|
|
Stock-based compensation on stock options, RSUs & RSAs
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
349,624 |
|
|
|
— |
|
|
|
— |
|
|
|
349,624 |
|
|
Foreign currency translation adjustment
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
92,383 |
|
|
|
— |
|
|
|
92,383 |
|
|
Net loss
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2,893,002 |
) |
|
|
(2,893,002 |
) |
|
Balances at September 30, 2025
|
|
|
24,956 |
|
|
$ |
34,232,510 |
|
|
|
44,670,213 |
|
|
$ |
446,702 |
|
|
$ |
253,529,806 |
|
|
$ |
1,071,069 |
|
|
$ |
(233,609,759 |
) |
|
$ |
21,437,818 |
|
LIGHTPATH TECHNOLOGIES, INC.
Condensed Consolidated Statements of Cash Flows
(unaudited)
| |
|
Three Months Ended
|
|
| |
|
September 30,
|
|
| |
|
2026
|
|
|
2025
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$ |
(1,700,754 |
) |
|
$ |
(2,893,002 |
) |
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
1,479,568 |
|
|
|
1,218,948 |
|
|
Interest from amortization of loan issuance costs
|
|
|
— |
|
|
|
38,312 |
|
|
Amortization of fair value of loan
|
|
|
— |
|
|
|
52,544 |
|
|
Change in fair value of acquisition earnout liabilities
|
|
|
196,633 |
|
|
|
1,282,529 |
|
|
Loss on disposal of property and equipment
|
|
|
30,849 |
|
|
|
3,999 |
|
|
Stock-based compensation on stock options, RSUs & RSAs, net
|
|
|
1,801,199 |
|
|
|
359,661 |
|
|
Provision for credit losses
|
|
|
48,827 |
|
|
|
(5,390 |
) |
|
Change in operating lease assets and liabilities
|
|
|
(18,687 |
) |
|
|
(60,448 |
) |
|
Inventory write-offs to allowance
|
|
|
46,512 |
|
|
|
— |
|
|
Deferred taxes
|
|
|
910 |
|
|
|
555 |
|
|
Changes in operating assets and liabilities, net of acquisitions:
|
|
|
|
|
|
|
|
|
|
Trade accounts receivable
|
|
|
(118,609 |
) |
|
|
(133,679 |
) |
|
Other current assets
|
|
|
(16,506 |
) |
|
|
27,800 |
|
|
Inventories
|
|
|
(13,527,486 |
) |
|
|
(3,335 |
) |
|
Prepaid expenses and deposits
|
|
|
993,394 |
|
|
|
127,786 |
|
|
Accounts payable and accrued liabilities
|
|
|
2,457,858 |
|
|
|
(1,159,122 |
) |
|
Net cash used in operating activities
|
|
|
(8,326,292 |
) |
|
|
(1,142,842 |
) |
| |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
(2,525,423 |
) |
|
|
(77,014 |
) |
|
Net cash used in investing activities
|
|
|
(2,525,423 |
) |
|
|
(77,014 |
) |
| |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of common stock from Employee Stock Purchase Plan
|
|
|
44,357 |
|
|
|
— |
|
|
Proceeds from issuance of common stock under private equity placement, net of fees
|
|
|
— |
|
|
|
7,894,045 |
|
|
Proceeds from sale-leaseback of equipment
|
|
|
591,974 |
|
|
|
— |
|
|
Payments on loans payable
|
|
|
(28,291 |
) |
|
|
(57,107 |
) |
|
Repayment of finance lease obligations
|
|
|
(77,258 |
) |
|
|
(55,398 |
) |
|
Net cash provided by financing activities
|
|
|
530,782 |
|
|
|
7,781,540 |
|
|
Effect of exchange rate on cash and cash equivalents
|
|
|
50,443 |
|
|
|
68,698 |
|
|
Change in cash and cash equivalents
|
|
|
(10,270,490 |
) |
|
|
6,630,382 |
|
|
Cash and cash equivalents, beginning of period
|
|
|
93,204,655 |
|
|
|
4,877,036 |
|
|
Cash and cash equivalents, end of period
|
|
$ |
82,934,165 |
|
|
$ |
11,507,418 |
|
| |
|
|
|
|
|
|
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
|
|
|
|
Interest paid in cash
|
|
$ |
24,358 |
|
|
$ |
177,963 |
|
|
Income taxes paid
|
|
$ |
222,352 |
|
|
$ |
56,282 |
|
|
Supplemental disclosure of non-cash investing & financing activities:
|
|
|
|
|
|
|
|
|
|
Issuance of common stock for acquisition of AML, including earnouts
|
|
$ |
1,622,879 |
|
|
|
— |
|
|
Operating right-of-use assets acquired in exchange for operating lease liabilities
|
|
|
— |
|
|
$ |
435,733 |
|
|
Issuance of common stock for acquisition of Visimid
|
|
|
— |
|
|
$ |
350,000 |
|
